Skip to main content
. 2019 Oct 8;41(38):3732–3739. doi: 10.1093/eurheartj/ehz698

Figure 1.

Figure 1

Thirty-day mortality adjusted for baseline risk. Thirty-day mortality after multivariable adjustment for baseline characteristics as assessed within 24 months previous to index EVR. Logistic regression model included co-prevalent cardiovascular risk factors, previous vascular procedures, as well as in-hospital complications and adverse events. Death (from any cause) at 30 days did not differ significantly between stent nor balloon angioplasty with vs. without paclitaxel (DES vs. BMS: OR 0.93, 95% confidence interval 0.57–1.53; P = 0.790; drug-coated balloon vs. POBA: OR 0.79, 95% confidence interval 0.59–1.07; P = 0.131). BL, baseline; BMS, bare-metal stent; CI, confidence interval; DCB, drug-coated balloon; DES, drug-eluting stent; EVR, endovascular revascularization; LEAD, lower extremity artery disease; OR, odds ratio; POBA, plain balloon angioplasty.